Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Accenture
Express Scripts
McKesson
Covington
Moodys
Merck
Dow
QuintilesIMS

Generated: September 22, 2018

DrugPatentWatch Database Preview

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Profile

« Back to Dashboard

When do Neomycin And Polymyxin B Sulfates And Bacitracin Zinc patents expire, and what generic alternatives are available?

Neomycin And Polymyxin B Sulfates And Bacitracin Zinc is a drug marketed by Akorn, Bausch And Lomb, and Perrigo Co Tennessee. and is included in three NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.

Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 065088-001 Feb 6, 2004 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064064-001 Oct 30, 1995 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Co Tennessee NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764-002 Approved Prior to Jan 1, 1982 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Accenture
Express Scripts
McKesson
Covington
Moodys
Merck
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.